Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Jim Cramer Reveals Where Investors Fled During Tariff Selloff & Discusses 10 Stocks

In this piece, we will look at the stocks that Jim Cramer discussed recently.

In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer discussed turmoil in the healthcare sector following the financial results of a major health insurer that sent the Dow index lower. Cramer speculated that had the outcome of the November 2024 US Presidential election been different, then the healthcare sector could face higher government scrutiny. Healthcare stocks were under pressure during the tail end of last year when the President (who was President-elect back then) had vowed to take on the healthcare middleman.

In December, Cramer had warned viewers not to buy the stocks of some of the largest healthcare benefits management companies. He commented:

“Look I think that if I were the people at [the benefits managers], when the President-elect decides that he is going to take a shot at you, as we know from his first time around, it’s not one off. There’s multiple shots. Multiple attempts to say listen you guys are . . . friction. I would not buy these stocks.”

However, Cramer’s concerns appeared to ‘taper off’ as the months progressed. In a February appearance following Trump’s oath-taking, the CNBC TV host wondered whether the Trump administration’s Justice Department was equipped to take on American healthcare giants. Cramer’s remarks were made in the context of hedge fund manager Bill Ackman advising against buying the stocks:

“Well, again, legislation can do something. This idea of, of creating policy through the Justice Department has not worked. The Justice Department has [inaudible] not been able to create changes. But Congress can. And that’s what has to happen. Look, do I agree with Ackman? I think, I favor universal healthcare [laughs] so I’m way off the reservation. But I do think that if Congress gets involved, as it did under, with Obamacare, they had a shot. Right at the end it was, it was destroyed by the Republican Party. But that’s, that’s what happens.”

This time around, Cramer commented on whether tighter government scrutiny of the companies’ coding practices could affect their loss ratios and drive them higher. According to him:

“Also when you mention that, because Jonathan Kanter now he’s the guy from antitrust, Justice, he was full bore United Health. Had, Harris won, I think these guys were going to be public enemy number one. They have spent so much time ready to go after UnitedHealth for being a monopolist. I will say by the way, the miss that they had on medical costs, I mean they have Optum, they’re supposed to know everything about medical costs. So this was very out of character, Carl. And also because of the weighting, it’s such a big stock, the weighting, it moves the Dow lower.”

He added:

“What was the Justice Department really after? You know, Justice Department, they were gonna gear up. They hadn’t hit this group yet. I think they were looking and saying, who haven’t we hit? You know the ex Justice Department, David, they were erratic. Not unlike what people think about some of the things that are going on, but oh, no one talks about them being erratic.”

Our Methodology

To make our list of the stocks that Jim Cramer talked about, we listed down the stocks he mentioned during CNBC’s Squawk on the Street aired on April 17th.

For these stocks, we also mentioned the number of hedge fund investors. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

10. CoreWeave, Inc. Class A Common Stock (NASDAQ:CRWV)

Number of Hedge Fund Holders In Q4 2024: 0 (Due To IPO in Q1 2025)

CoreWeave, Inc. Class A Common Stock (NASDAQ:CRWV) is a cloud platform provider that provides equipment for AI and other computing purposes. It is the first IPO in 2025, and the shares have lost 12.9% since they started trading. Cramer has discussed CoreWeave, Inc. Class A Common Stock (NASDAQ:CRWV) in detail previously. He has wondered whether the firm’s GPUs will hold their value after depreciation and dismissed reports that it was created by NVIDIA to create GPU demand. Here are his latest thoughts about CoreWeave, Inc. Class A Common Stock (NASDAQ:CRWV):

“CoreWeave, if you look at what CoreWeave’s doing, a lot of it is with OpenAI.”

9. Chagee Holdings Limited American Depositary Shares (NASDAQ:CHA)

Number of Hedge Fund Holders In Q4 2024: 0 (Due To IPO in Q1 2025)

Chagee Holdings Limited American Depositary Shares (NASDAQ:CHA)’s shares IPO’d on the day this program was aired. The firm is a Chinese tea company that operates teahouses and sells associated products. Since the listing, the stock has lost 6% as it gets caught up in the market turmoil surrounding the trade war between the US and China. As the shares started trading at the opening bell, here’s what Cramer said about Chagee Holdings Limited American Depositary Shares (NASDAQ:CHA):

“We give them Jensen Huang, what do they give us? I’ll pick Jensen over Chagee any day.”

8. KeyCorp (NYSE:KEY)

Number of Hedge Fund Holders In Q4 2024: 43

KeyCorp (NYSE:KEY) is an American regional bank that offers commercial and consumer banking services. Its shares have lost 18% year-to-date as they suffered during April’s tariff-induced stock market selloff. KeyCorp (NYSE:KEY)’s shares dipped by 12% on April 2nd and have yet to recover the losses. In his previous comments about the stock, Cramer said that he liked the stock because of its dividend. Here are his latest thoughts:

“You know I had KEY on. KEY has had an important anniversary, in you know like two hundred years. There’s only fifty companies that have two hundred years in business. And yet it yields 5.65 and they’re doing very, very well. Ohio is doing incredibly well as a state in terms of where people are putting, they’re putting a lot of data center-like things in Ohio. Of course Microsoft, being the only monkey wrench in the process.”

7. Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Number of Hedge Fund Holders In Q4 2024: 46

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) is a struggling pharmacy retailer whose shares are among the worst performers on the market. The stock has lost 40% over the past year and trimmed the losses by gaining 15% year-to-date. Walgreens Boots Alliance, Inc. (NASDAQ:WBA)’s recent share price performance is due to the confirmation of the firm going private. Cramer believes there’s pain ahead for the firm’s operations:

“CVS is the star right now. And CVS of course you have to believe that there’s going to be a mass closing of Walgreens. Because they’ve got, Sycamore’s got the clock ticking on that one.”

6. CSX Corporation (NASDAQ:CSX)

Number of Hedge Fund Holders In Q4 2024: 63

CSX Corporation (NASDAQ:CSX) is one of the largest railroad companies in America with operations in the US and Canada. Its shares have lost 15% year-to-date after having dipped by 10% during the days after President Trump’s tariffs came into effect on April 2nd. Here is what Cramer said about CSX Corporation (NASDAQ:CSX):

“You guys have CSX, Joseph Hinrichs, coming up, and, sometimes, with railroads so many things could go wrong, in infrastructure . . they have a . . .tunnel they have to worry about. And people are willing to forgive today. Because, Joe, the CEO, he’s going to be very repentant. He didn’t think he did a good job. And that the stock’s up. There is a bias today. Towards saying that things are a little bit better. This is not a bad day. . . So there is an element of forgiveness today that I want to note for the companies that are reporting.”

5. Shopify Inc. (NASDAQ:SHOP)

Number of Hedge Fund Holders In Q4 2024: 64

Shopify Inc. (NASDAQ:SHOP) is a Canadian eCommerce company that allows merchants and retailers to sell their products and launch and operate digital storefronts. Its shares are down by 25% year-to-date with the selloff accelerating since the April 2nd tariff-induced stock market selloff. In his recent remarks about Shopify Inc. (NASDAQ:SHOP), Cramer has called the stock a winner and advised viewers against not trading them. Here are his latest thoughts:

“It’s very, it’s very confusing to think here what’s going on with De Minimis. Moffett Nathanson’s piece is very very bad for Shopify. All I can tell you is this that De Minimis will sort itself out, and I would not. . . “

4. Humana Inc. (NYSE:HUM)

Number of Hedge Fund Holders In Q4 2024: 64

Humana Inc. (NYSE:HUM) is one of the largest healthcare insurance and benefits providers in America. Its sector was a key theme in Cramer’s show as he commented on healthcare giant UnitedHealth’s stunning earnings that sent the shares down by 17.4%. The CNBC host wondered whether the poor earnings were a firm-specific factor for UNH and UnitedHealth Group Incorporated (NYSE:UNH) factored into the discussion:

“Humana already went through this. So Humana’s getting hammered. I thought Humana bounced back. I’m not saying anything’s isolated. Because as soon as you . . .there’s going to be some sort of well cockroach theory.”

3. Global Payments Inc. (NYSE:GPN)

Number of Hedge Fund Holders In Q4 2024: 71

Global Payments Inc. (NYSE:GPN) is a fintech company that offers payment processing and issuer solutions. As a result, the firm’s shares are dependent on overall economic performance as it leads to higher transaction volumes on its platform. Global Payments Inc. (NYSE:GPN)’s shares have lost a whopping 40.6% year-to-date and have lost 33% since the April tariff selloff. The most recent dip in the shares came after investors fled the stock as it announced an acquisition that muddied its turnaround expectations. Here’s what Cramer said the day the shares fell:

“People should know that it’s PayPal, Stripe, Square, all against them. And I think that these guys could be very powerful versus those. . . . Maybe this is against Stripe.”

2. Centene Corporation (NYSE:CNC)

Number of Hedge Fund Holders In Q4 2024: 71

Centene Corporation (NYSE:CNC) is one of the largest healthcare insurance companies in America. Due to the recent disastrous earnings results of UnitedHealth that sent the stock down by 17.4%, the firm was part of the discussion in Cramer’s show. Centene Corporation (NYSE:CNC)’s shares have lost 3.7% year-to-date as healthcare stocks have provided tariff-weary investors shelter from an otherwise painful market bloodbath. Here’s what Cramer said about the firm:

“Centene is an issue about what they’re going to do with Medicaid. But Centene’s doing incredibly well.”

1. CVS Health Corporation (NYSE:CVS)

Number of Hedge Fund Holders In Q4 2024: 74

CVS Health Corporation (NYSE:CVS) is a mega-American pharmacy chain operator. It has benefited due to the trouble that its peer Walgreens has faced for more than a year. CVS Health Corporation (NYSE:CVS)’s shares are up by 47% year-to-date, and Cramer’s previous remarks about the firm have pointed out that its Aetna division is benefiting from Walgreens’ troubles. As UNH stock tumbled, here’s what Cramer said about CVS Health Corporation (NYSE:CVS):

[UNH taking the year down 12% when it came to EPS] [CVS] “I checked in with CVS, with Aetna, they reiterated recently. They said everything was fine. . . I was just looking at the statement, I’m saying, wow, totally contrary. This is so unlike UNH.”

[CVS-on managed care companies suffering from seniors using more than they thought] “Some people feel Karen Lynch lost her job for that, because she was from that division. . CVS. In retrospect, how bad was she really?”

“[On how folks were hiding in the stocks during the tariff havoc] Oh yeah, no, I wanted to hide. I was talking about it in my, in my club call yesterday. I said listen we gotta find a place to hide in this group. I’ve been inclined to do CVS because CVS is in a situation where they’re gonna close so many Walgreens. There’s so many. . .closed that they’re the last ones standing. Now they didn’t really like that characterization. They said listen, they’re the best. And I don’t mind saying that because I think CVS is the best. But wow, you gotta pivot here.”

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure. None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.